Press Resease

Platelet Aggregation Devices Market - Global Industry Analysis

Platelet Aggregation Devices Market (Systems, Reagents And Consumables & Accessories) For Standalone Hospitals, Diagnostic Laboratories, Research & Academic Institutes And Other End-Users: Global Industry Perspective, Comprehensive Analysis And Forecast, 2020 – 2028

Published Date: 26-Jun-2021 Category: Medical Device Report Format : PDF Pages: 122 Report Code: ZMR-925 Status : Published

The global Platelet Aggregation Devices market accounted for USD 356.8 Million in 2020 and is expected to reach USD 640.3 Million by 2028, growing at a CAGR of 7.3% from 2021 to 2028.

Description

Market Overview   

The global Platelet Aggregation Devices market accounted for USD 356.8 Million in 2020 and is expected to reach USD 640.3 Million by 2028, growing at a CAGR of 7.3% from 2021 to 2028.  

The major catalysts for the platelet aggregation devices market comprise rising demand for platelet screening initiatives to verify diseases like Dengue and HIV. Additionally, to the present, the platelet aggregation devices market is likely to power demand from the patient population browsing antiplatelet treatment. Besides this, the rising aged population everywhere on the planet paired with the increasing cases of target diseases also are likely to elevate the event of platelet aggregation devices market in years to return. Moreover, the broad range of platelet aggregation devices’ new applications like recognition of genetically obtained platelet defects and evaluation of surgical bleeding risk also is likely to power the expansion of the platelet aggregation devices market within the near future. On the flip side, the limited scope at the extent of end-users and the high price of purchase are likely to hinder the expansion of the platelet aggregation devices market in years to return.

Despite these limitations, R&D within the platelet aggregation devices market is probably going to be a chance for market growth within the near future. as an example, in September 2017, RMIT and Monash researchers edged nearer to refining a gadget that will rapidly calculate platelet function within the people’s blood that is affected by Willebrand's disease.

COVID-19 Impact Analysis:

The outbreak of COVID-19 worldwide is additionally expected to possess a positive impact on the market, and there's strong evidence that SARS-CoV-2 infection is related to atherothrombotic phenomena. Consistent with the National clinical test Registry (NCT), currently, there are about three clinical trials to work out the effect of COVID-19 on platelet aggregation, which is predicted to drive the platelet aggregation devices market within the coming years. The platelet aggregation devices are meant to treat various cardiovascular diseases and bleeding disorders, but the COVID-19 pandemic is predicted to affect the treatment for these diseases and therefore the supply chain of the devices across the planet.

Growth Factors

Aspects such as rising incidences of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometer, and an increasing number of industry-academia collaborations and clinical studies are boosting the growth of the global market. The significant increase in the number of people suffering from cardiovascular diseases ultimately increases the use of platelet aggregation devices to study platelet aggregation worldwide and may drive the market over the forecast period. However, procedural limitations, unfavorable Diagnostic Laboratories reforms in the U.S., and a dearth of well-trained and skilled professionals are some of the key factors restraining the growth of this market.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Segment Analysis Preview

The Platelet Aggregation Devices market is segmented based on the product, application, end-user and region. Based on product the platelet aggregation devices market is segmented into systems, reagents, consumables & accessories. Based on the application the platelet aggregation device market is segmented into clinical applications and research applications. Based on end-user, it is categorized into; standalone hospitals, research, and academic institutes, diagnostic laboratories, and other end users.

Based on the product, the systems segment is expected to show decent growth over the forecast period. The platelet aggregation system or aggregometer is employed to work out how well the platelets stay together. Such systems measure platelet aggregation with the utilization of a platelet antagonist, like ADP, thrombin, and ristocetin. Aggregation systems are likely to grow over the forecast period due to factors, like continuous technological advances within the field of platelet aggregation devices, the escalation of trends in platelet aggregation testing methods, growing adoption and market preference of automated systems among diagnostic laboratories, and growing advantages offered by point-of-care testing analyzers, as compared to standard instruments.

Based on the application segment, clinical applications dominated the market, however, the rising COVID-19 cases and therefore the lockdown and inhibitions on the intercountry transport were found to possess an impression on the availability chain of the systems. Many manufacturers have stopped production due to the shortage of labor that's found to impact the segment growth. Though, the increasing evidence of the effect of COVID-19 on platelet aggregation is resulting in rising research studies on the method.

Based on the End User segment, the need for platelet aggregation systems is growing within the academic and pharmaceutical companies due to the rise in research studies, mostly to understand the mechanisms involved within the interaction of platelets with vascular surfaces and evaluation and screening of anti-thrombotic factors to understand new targets for antiplatelet drugs. Furthermore, the businesses also are taking initiatives to develop their products and expand their presence within the market. 

Based on region, in 2018 North America added up for the most important share of the platelet aggregation devices market. it's also likely to develop at the uppermost CAGR within the near future. The U.S. holds the most important share of the platelet aggregation devices market in North America thanks to the attendance of leading players during this area. Moreover, the increasing number of surgical operations, the huge patient population for target diseases, a major number of patients browsing cardiovascular operations, rising awareness amongst Diagnostic Laboratories experts, and rising occurrence of urological, orthopedic, & bleeding disorders also are likely to power the event of platelet aggregation devices market in years to return.

Key Market Players & Competitive Landscape

Some of the key players profiled in the report include Major players active in the global platelet aggregation devices market are Helena Laboratories Corporation, Siemens AG, Accriva Diagnostics, Haemonetics Corporation, Helena Laboratories Corporation, F. Hoffman-La Roche Ltd, Aggredyne, Inc., Sysmex Corporation, Sentinel Ch. S.P.A., and TEM Group among others. These players are set to foster the development of global platelet aggregation devices market in the forecast market.

The global Platelet Aggregation Devices market is segmented as follows:   

By Product

  • Systems 
  • Reagents 
  • Consumables & Accessories

By Application

  • Clinical Applications 
  • Research Applications

By End User

  • Standalone Hospitals
  • Research and Academic Institutes
  • Diagnostic Laboratories
  • Other End-Users

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Product
        • 2.1.1.2. Market Attractiveness Analysis, By Application
        • 2.1.1.3. Market Attractiveness Analysis, By End User
        • 2.1.1.4. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Platelet Aggregation Devices Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Platelet Aggregation Devices Market – Product Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Product, 2020 & 2028
    • 4.2. Systems
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Reagents
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Consumables & Accessories
      • 4.4.1. Market Size and Forecast, By Region (USD Million)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Platelet Aggregation Devices Market – Application Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Application, 2020 & 2028
    • 5.2. Clinical Applications
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Research Applications
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Platelet Aggregation Devices Market – Application Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By End User, 2020 & 2028
    • 6.2. Standalone Hospitals
      • 6.2.1. Market Size and Forecast, By Region (USD Million)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Research and Academic Institutes
      • 6.3.1. Market Size and Forecast, By Region (USD Million)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.4. Diagnostic Laboratories
      • 6.4.1. Market Size and Forecast, By Region (USD Million)
      • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.5. Others
      • 6.5.1. Market Size and Forecast, By Region (USD Million)
      • 6.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.5.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7 Platelet Aggregation Devices Market – Regional Analysis
    • 7.1. Overview
      • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 7.2. North America
      • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.2.2. North America Market Revenue, By Product, 2016 – 2028
      • 7.2.3. North America Market Revenue, By Application, 2016 – 2028
      • 7.2.4. North America Market Revenue, By End User, 2016 – 2028
      • 7.2.5. U.S.
        • 7.2.5.1. U.S. Market Revenue, By Product, 2016 – 2028
        • 7.2.5.2. U.S. Market Revenue, By Application, 2016 – 2028
        • 7.2.5.3. U.S. Market Revenue, By End User, 2016 – 2028
      • 7.2.6. Canada
        • 7.2.6.1. Canada Market Revenue, By Product, 2016 – 2028
        • 7.2.6.2. Canada Market Revenue, By Application, 2016 – 2028
        • 7.2.6.3. Canada Market Revenue, By End User, 2016 – 2028
      • 7.2.7. Mexico
        • 7.2.7.1. Mexico Market Revenue, By Product, 2016 – 2028
        • 7.2.7.2. Mexico Market Revenue, By Application, 2016 – 2028
        • 7.2.7.3. Mexico Market Revenue, By End User, 2016 – 2028
    • 7.3. Europe
      • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.3.2. Europe Market Revenue, By Product, 2016 – 2028
      • 7.3.3. Europe Market Revenue, By Application, 2016 – 2028
      • 7.3.4. Europe Market Revenue, By End User, 2016 – 2028
      • 7.3.5. Germany
        • 7.3.5.1. Germany Market Revenue, By Product, 2016 – 2028
        • 7.3.5.2. Germany Market Revenue, By Application, 2016 – 2028
        • 7.3.5.3. Germany Market Revenue, By End User, 2016 – 2028
      • 7.3.6. France
        • 7.3.6.1. France Market Revenue, By Product, 2016 – 2028
        • 7.3.6.2. France Market Revenue, By Application, 2016 – 2028
        • 7.3.6.3. France Market Revenue, By End User, 2016 – 2028
      • 7.3.7. U.K.
        • 7.3.7.1. U.K. Market Revenue, By Product, 2016 – 2028
        • 7.3.7.2. U.K. Market Revenue, By Application, 2016 – 2028
        • 7.3.7.3. U.K. Market Revenue, By End User, 2016 – 2028
      • 7.3.8. Italy
        • 7.3.8.1. Italy Market Revenue, By Product, 2016 – 2028
        • 7.3.8.2. Italy Market Revenue, By Application, 2016 – 2028
        • 7.3.8.3. Italy Market Revenue, By End User, 2016 – 2028
      • 7.3.9. Spain
        • 7.3.9.1. Spain Market Revenue, By Product, 2016 – 2028
        • 7.3.9.2. Spain Market Revenue, By Application, 2016 – 2028
        • 7.3.9.3. Spain Market Revenue, By End User, 2016 – 2028
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Market Revenue, By Product, 2016 – 2028
        • 7.3.10.2. Rest of Europe Market Revenue, By Application, 2016 – 2028
        • 7.3.10.3. Rest of Europe Market Revenue, By End User, 2016 – 2028
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.4.2. Asia Pacific Market Revenue, By Product, 2016 – 2028
      • 7.4.3. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 7.4.4. Asia Pacific Market Revenue, By End User, 2016 – 2028
      • 7.4.5. China
        • 7.4.5.1. China Market Revenue, By Product, 2016 – 2028
        • 7.4.5.2. China Market Revenue, By Application, 2016 – 2028
        • 7.4.5.3. China Market Revenue, By End User, 2016 – 2028
      • 7.4.6. Japan
        • 7.4.6.1. Japan Market Revenue, By Product, 2016 – 2028
        • 7.4.6.2. Japan Market Revenue, By Application, 2016 – 2028
        • 7.4.6.3. Japan Market Revenue, By End User, 2016 – 2028
      • 7.4.7. India
        • 7.4.7.1. India Market Revenue, By Product, 2016 – 2028
        • 7.4.7.2. India Market Revenue, By Application, 2016 – 2028
        • 7.4.7.3. India Market Revenue, By End User, 2016 – 2028
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Market Revenue, By Product, 2016 – 2028
        • 7.4.8.2. South Korea Market Revenue, By Application, 2016 – 2028
        • 7.4.8.3. South Korea Market Revenue, By End User, 2016 – 2028
      • 7.4.9. South-East Asia
        • 7.4.9.1. South-East Asia Market Revenue, By Product, 2016 – 2028
        • 7.4.9.2. South-East Asia Market Revenue, By Application, 2016 – 2028
        • 7.4.9.3. South-East Asia Market Revenue, By End User, 2016 – 2028
      • 7.4.10. Rest of Asia Pacific
        • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Product, 2016 – 2028
        • 7.4.10.2. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
        • 7.4.10.3. Rest of Asia Pacific Market Revenue, By End User, 2016 – 2028
    • 7.5. Latin America
      • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.5.2. Latin America Market Revenue, By Product, 2016 – 2028
      • 7.5.3. Latin America Market Revenue, By Application, 2016 – 2028
      • 7.5.4. Latin America Market Revenue, By End User, 2016 – 2028
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Market Revenue, By Product, 2016 – 2028
        • 7.5.5.2. Brazil Market Revenue, By Application, 2016 – 2028
        • 7.5.5.3. Brazil Market Revenue, By End User, 2016 – 2028
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Market Revenue, By Product, 2016 – 2028
        • 7.5.6.2. Argentina Market Revenue, By Application, 2016 – 2028
        • 7.5.6.3. Argentina Market Revenue, By End User, 2016 – 2028
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Market Revenue, By Product, 2016 – 2028
        • 7.5.7.2. Rest of Latin America Market Revenue, By Application, 2016 – 2028
        • 7.5.7.3. Rest of Latin America Market Revenue, By End User, 2016 – 2028
    • 7.6. The Middle-East and Africa
      • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.6.2. The Middle-East and Africa Market Revenue, By Product, 2016 – 2028
      • 7.6.3. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
      • 7.6.4. The Middle-East and Africa Market Revenue, By End User, 2016 – 2028
      • 7.6.5. GCC Countries
        • 7.6.5.1. GCC Countries Market Revenue, By Product, 2016 – 2028
        • 7.6.5.2. GCC Countries Market Revenue, By Application, 2016 – 2028
        • 7.6.5.3. GCC Countries Market Revenue, By End User, 2016 – 2028
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Market Revenue, By Product, 2016 – 2028
        • 7.6.6.2. South Africa Market Revenue, By Application, 2016 – 2028
        • 7.6.6.3. South Africa Market Revenue, By End User, 2016 – 2028
      • 7.6.7. Rest of Middle-East Africa
        • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Product, 2016 – 2028
        • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
        • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By End User, 2016 – 2028
  • Chapter No. 8 Platelet Aggregation Devices Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
      • 8.2.1. Driving Factor 1 Analysis
      • 8.2.2. Driving Factor 2 Analysis
    • 8.3. Market Restraints
      • 8.3.1. Restraining Factor Analysis
    • 8.4. Market Opportunities
      • 8.4.1. Market Opportunity Analysis
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Technology Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9 Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global Platelet Aggregation Devices Market: Company Market Share, 2019
      • 9.1.2. Global Platelet Aggregation Devices Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 9.1.3. Global Platelet Aggregation Devices Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global Platelet Aggregation Devices Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Product Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10 Company Profiles
    • 10.1. Helena Laboratories Corporation
      • 10.1.1. Company Overview
      • 10.1.2. Key Executives
      • 10.1.3. Product Portfolio
      • 10.1.4. Financial Overview
      • 10.1.5. Operating Business Segments
      • 10.1.6. Business Performance
      • 10.1.7. Recent Developments
    • 10.2. Siemens AG
    • 10.3. Accriva Diagnostics
    • 10.4. Haemonetics Corporation
    • 10.5. Helena Laboratories Corporation
    • 10.6. F. Hoffman-La Roche Ltd
    • 10.7. Aggredyne, Inc.
    • 10.8. Sysmex Corporation
    • 10.8. Sentinel Ch. S.P.A.
    • 10.9. TEM Group
    • 10.10 Others
  • Chapter No. 11 Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Environmental Change
  • Chapter No. 12 Research Methodology
    • 12.1. Research Methodology
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Product
FIG NO. 2. Market Attractiveness Analysis, By Application
FIG NO. 4. Market Attractiveness Analysis, By Region
FIG NO. 5. Global Platelet Aggregation Devices Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 6. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 7. Market Revenue Share, By Product, 2020 & 2028
FIG NO. 8. Global Platelet Aggregation Devices Market for Systems, Revenue (USD Million) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of Platelet Aggregation Devices Market for Systems, By Country, 2020 & 2028
FIG NO. 10. Global Platelet Aggregation Devices Market for Reagents, Revenue (USD Million) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of Platelet Aggregation Devices Market for Reagents, By Country, 2020 & 2028
FIG NO. 12. Global Platelet Aggregation Devices Market for Consumables & Accessories, Revenue (USD Million) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of Platelet Aggregation Devices Market for Consumables & Accessories, By Country, 2020 & 2028
FIG NO. 14. Market Revenue Share, By Application, 2020 & 2028
FIG NO. 15. Global Platelet Aggregation Devices Market for Clinical Applications, Revenue (USD Million) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Platelet Aggregation Devices Market for Clinical Applications, By Country, 2020 & 2028
FIG NO. 17. Global Platelet Aggregation Devices Market for Research Applications, Revenue (USD Million) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Platelet Aggregation Devices Market for Research Applications, By Country, 2020 & 2028
FIG NO. 19. Market Revenue Share, By End User, 2020 & 2028
FIG NO. 20. Global Platelet Aggregation Devices Market for Standalone Hospitals, Revenue (USD Million) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Platelet Aggregation Devices Market for Standalone Hospitals, By Country, 2020 & 2028
FIG NO. 22. Global Platelet Aggregation Devices Market for Research and Academic Institutes, Revenue (USD Million) 2016 – 2028
FIG NO. 23. Comparative Revenue Analysis of Platelet Aggregation Devices Market for Research and Academic Institutes, By Country, 2020 & 2028
FIG NO. 24. Global Platelet Aggregation Devices Market for Diagnostic Laboratories, Revenue (USD Million) 2016 – 2028
FIG NO. 25. Comparative Revenue Analysis of Platelet Aggregation Devices Market for Diagnostic Laboratories, By Country, 2020 & 2028
FIG NO. 26. Global Platelet Aggregation Devices Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 27. Comparative Revenue Analysis of Platelet Aggregation Devices Market for Others, By Country, 2020 & 2028
FIG NO. 28. Global Platelet Aggregation Devices Market Revenue Share, By Region, 2020 & 2028
FIG NO. 29. North America Platelet Aggregation Devices Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 30. Porter’s Five Forces Analysis for Global Platelet Aggregation Devices Market
FIG NO. 31. PEST Analysis for Global Platelet Aggregation Devices Market
FIG NO. 32. Pricing Analysis for Global Platelet Aggregation Devices Market
FIG NO. 33. Value Chain Analysis for Global Platelet Aggregation Devices Market
FIG NO. 34. Company Share Analysis, 2019
FIG NO. 35. Radar Determinant Chart, 2019
FIG NO. 36. Company Strategic Developments – Heat Map Analysis
FIG NO. 37. STMicroelectronics NV Business Segment Revenue Share, 2020 (%)
FIG NO. 38. STMicroelectronics NV Geographical Segment Revenue Share, 2020 (%)
FIG NO. 39. Market Channels
FIG NO. 40. Marketing Channel Development Trend
FIG NO. 41. Growth in World Gross Product, 2008-2018
FIG NO. 42. Research Methodology – Detailed View
FIG NO. 46. Research Methodology


List of Tables 

TABLE NO. 1. Global Platelet Aggregation Devices Market: Snapshot
TABLE NO. 2. Quarterly Platelet Aggregation Devices Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Platelet Aggregation Devices Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 6. Global Platelet Aggregation Devices Market for Systems, by Region, 2016 – 2028 (USD Million)
TABLE NO. 7. Global Platelet Aggregation Devices Market for Reagents, by Region, 2016 – 2028 (USD Million)
TABLE NO. 8. Global Platelet Aggregation Devices Market for Consumables & Accessories, by Region, 2016 – 2028 (USD Million)
TABLE NO. 9. Global Platelet Aggregation Devices Market for Clinical Applications, by Region, 2016 – 2028 (USD Million)
TABLE NO. 10. Global Platelet Aggregation Devices Market for Research Applications, by Region, 2016 – 2028 (USD Million)
TABLE NO. 11. Global Platelet Aggregation Devices Market for Standalone Hospitals, by Region, 2016 – 2028 (USD Million)
TABLE NO. 12. Global Platelet Aggregation Devices Market for Research and Academic Institutes, by Region, 2016 – 2028 (USD Million)
TABLE NO. 13. Global Platelet Aggregation Devices Market for Diagnostic Laboratories, by Region, 2016 – 2028 (USD Million)
TABLE NO. 14. Global Platelet Aggregation Devices Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 15. Global Platelet Aggregation Devices Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 16. Global Platelet Aggregation Devices Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 17. North America Platelet Aggregation Devices Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 18. North America Platelet Aggregation Devices Market Revenue, By Product, 2016 – 2028 (USD Million)
TABLE NO. 19. North America Platelet Aggregation Devices Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 20. North America Platelet Aggregation Devices Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 21. U.S. Platelet Aggregation Devices Market Revenue, By Product, 2016 – 2028 (USD Million)
TABLE NO. 22. U.S. Platelet Aggregation Devices Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 23. U.S. Platelet Aggregation Devices Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 24. Canada Platelet Aggregation Devices Market Revenue, By Product, 2016 – 2028 (USD Million)
TABLE NO. 25. Canada Platelet Aggregation Devices Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 26. Canada Platelet Aggregation Devices Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 27. Mexico Platelet Aggregation Devices Market Revenue, By Product, 2016 – 2028 (USD Million) 
TABLE NO. 28. Mexico Platelet Aggregation Devices Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 29. Mexico Platelet Aggregation Devices Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 30. Drivers for the Platelet Aggregation Devices Market: Impact Analysis
TABLE NO. 31. Restraints for the Platelet Aggregation Devices Market: Impact Analysis
TABLE NO. 32. Major Buyers of Platelet Aggregation Devices
TABLE NO. 33. Distributors/Traders List of Platelet Aggregation Devices 
TABLE NO. 34. Global Platelet Aggregation Devices Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 35. Global Platelet Aggregation Devices Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)
 
 

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Platelet Aggregation Devices market. Zion Research has collected and analyzed key data belong to the global Platelet Aggregation Devices market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Platelet Aggregation Devices across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Platelet Aggregation Devices industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases, and market reports

News articles, press releases, and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Platelet Aggregation Devices market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage, and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Platelet aggregation devices market is expected to witness a significant growth owing to rising incidence of diseases such as dengue and malaria in Asia and a significant patient population undergoing surgeries across the world is expected to fuel the global platelet aggregation devices in coming five years.  Platelets are types of blood cells which are also known as blood clot cells whose function is to stop bleeding by clumping and clotting blood vessel injuries. Without platelets, someone could bleed to death. Abnormal platelet aggregation leads to life-threatening disorders such as Glanzmann Thrombasthenia. Platelet aggregation disorder is hereditary or acquired. A platelet aggregation test checks how well the platelets clump together. Various medical devices are used to examine the platelet aggregation disorder. As per the centers for disease control and prevention (USA Gov.) hemophilia affects 1 in 5,000 male births and about 400 babies are born with hemophilia each year in U.S. In addition, age has a significant effect on platelet aggregation behavior so the geriatric population across the globe is expected to be one of the driving factors of the demand for platelet aggregation devices within the forecast period.

With the increasing number of platelet aggregation disorders, the demand for the platelet aggregation devices is increasing rapidly. In addition, major growth drivers for the platelet aggregation devices market are increasing the incidence of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometer within the forecast period. Furthermore, the demand for platelet aggregation devices is also expected to fuel by some other factors like increasing number of surgeries, increasing awareness and development of new technology in platelet aggregation devices market. In addition, increasing the incidence of disorders like; thrombocythemia; an abnormal increase in the number of platelets and thrombocytopenia; a decrease in the number of platelets) is expected to boost the demand for platelet function test market during the forecast period. However, the high cost of purchase, the dearth of well trained & skilled professionals and unfavorable healthcare reforms in the U.S. are expected to decelerate the growth in this market in coming five years. In spite of these restraints, research and development in the platelet devices market are expected to be an opportunity for this market in the forecast period.

Global-Platelet-Aggregation-Devices-Market

On the basis of product, the global platelet aggregation devices market is categorized into; systems, reagents and consumables & accessories. In this segment, platelet aggregation systems dominated the market by accounting for the largest share of the global market in 2016. Major growth driver for the demand of systems includes continuous technological advancements in the field of sensors and detectors coupled with growing adoption & market preference for automated instruments among diagnostic laboratories.

On the basis of application, the platelet aggregation devices market segment is categorized into clinical applications and research applications. The application segment is expected to dominate by clinical applications owing to increasing awareness among healthcare professionals about the benefits of platelet healthcare devices supplemented by the increasing incidences of the target diseases. In addition, increasing geriatric population globally is also expected to boost the demand of these devices in the clinical application within the forecast period.

An end-user segment of the platelet aggregation devices market includes the: standalone hospitals, research and academic institutes, diagnostic laboratories and other end users.  In this segment, standalone hospitals are expected to capture the largest market share of the global platelet aggregation devices market in coming five years owing to the benefits offered by hospitals in conducting the platelet aggregation testing procedure, large patient population base for diseases such as bleeding disorders, cardiovascular diseases, and arthritis.

North America accounted for largest share of this market in 2016 and is expected to witness the fastest growth in global platelet aggregation devices market in coming five years. U.S. had the largest market share in platelet aggregation devices market in this region. The North American region has become the attractive destination for platelet aggregation products manufacturing companies due to the large patient population for target diseases; a significant number of patients undergoing cardiovascular surgeries and increasing prevalence of urological and bleeding disorders.

Europe is expected to attribute for the second largest position in this market within the forecast period due to the presence of leading manufacturers of platelet aggregation devices in this region coupled with increasing rate of clinical research Furthermore, especially in Italy, a large number of people suffering from cardiovascular disease, neoplasm, and strokes are also expected to fuel the demand for platelet aggregation devices in this region in coming five years. Asia Pacific is expected to be one of the attractive markets for platelet aggregation devices within the forecast period owing to the increasing incidences of mosquito-borne diseases such as malaria and dengue.

Latin America is expected to show an above average growth due to increasing awareness among healthcare professionals related to the benefits of platelet aggregation testing in various diseases diagnosis. In the Middle East and South Africa, market growth for platelet aggregation devices is expected to boost by improving political stability and increasing awareness related to platelet disorders.

Some of the key players of green building market such as Siemens AG, Helena Laboratories Corporation, Haemonetics Corporation, Accriva Diagnostics, F. Hoffman-La Roche Ltd, Helena Laboratories Corporation, Sysmex Corporation, Aggredyne, Inc., TEM Group, Sentinel Ch. S.P.A. among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global Platelet Aggregation Devices market was valued at USD 356.8 Million in 2020.

The global Platelet Aggregation Devices market is expected to reach USD 640 Million by 2028, growing at a CAGR of 7.3% between 2021 to 2028.

The major factors attributing to the growth of the platelet aggregation devices market are the rising burden of chronic diseases, the increasing geriatric population, and technological advancements in platelet aggregometer.

Regionally, North America has been leading the worldwide Platelet Aggregation Devices market and is anticipated to continue in the dominant position in the years to come.

Some of the major companies operating in the Platelet Aggregation Devices market are Helena Laboratories Corporation, Siemens AG, Accriva Diagnostics, Haemonetics Corporation, Helena Laboratories Corporation, F. Hoffman-La Roche Ltd, Aggredyne, Inc., Sysmex Corporation, Sentinel Ch. S.P.A., and TEM Group among others. 
 

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed